Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The human immunodeficiency virus (HIV) rapid test kits market was valued at 1100.41 Million in 2025. It is poised to grow at a CAGR of 7.31% during the forecast period of 2026-2035, and reach 2228.21 Million by 2035. The market growth is driven by rising HIV prevalence, increasing demand for early and accurate diagnosis, expanding point-of-care testing adoption, and continuous improvements in diagnostic technologies and public health initiatives.
Base Year
Historical Period
Forecast Period
In April 2026, AIIMS Mangalagiri introduced nucleic acid-based HIV testing systems, improving early detection accuracy, reducing diagnostic window periods, and enhancing intervention efficiency.
In February 2026, Canada approved expanded distribution of the OraQuick oral HIV self-test, enabling national retail and pharmacy rollout.
In October 2025, bioLytical Laboratories Inc. received FDA approval for INSTI HIV Self-Test, enabling one-minute finger-prick results and improving rapid, accessible HIV screening globally.
Compound Annual Growth Rate
7.31%
Value in Million
2026-2035
*this image is indicative*
The rapid testing kits market for HIV infection is expanding steadily due to rising global HIV prevalence, increasing demand for early detection, and growing adoption of point-of-care diagnostics. Technological advancements, improved accessibility, and supportive public health initiatives are further strengthening growth, enabling faster diagnosis, better treatment linkage, and enhanced disease management across diverse healthcare settings worldwide. The market reached a value of approximately 1100.41 Million in 2025.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advancements in Molecular Diagnostics to Boost the Market Demand
Increasing focus on early-stage infection detection and improved diagnostic sensitivity is driving molecular testing adoption globally. For instance, in April 2026, AIIMS Mangalagiri in India introduced advanced nucleic acid-based HIV detection systems to shorten diagnostic window periods. This innovation is expected to enhance screening accuracy and strengthen early intervention strategies during the forecast period.
Key trends shaping the market include rising adoption of self-testing kits, expansion of point-of-care diagnostics, increasing regulatory approvals, and growing integration of digital health technologies for faster HIV detection.
Rapid Diagnostic Innovation and Self-Testing Expansion Strengthening the Market Advancement
Rising demand for early diagnosis and increasing adoption of decentralized healthcare models are accelerating self-testing adoption globally. For instance, in October 2025, bioLytical Laboratories Inc. received FDA approval for the INSTI HIV Self-Test, enabling results within one minute using finger-prick blood samples. This development is expected to improve testing accessibility and strengthen market growth during the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Sample Type
Market Breakup by Distribution Channel
Market Breakup by End User
Market Breakup by Region
Retail Pharmacies Expected to Dominate the Market Segment by Distribution Channel
Retail pharmacies dominated the distribution landscape, accounting for about 41% of total volume in the historical period. The dominance is driven by strong accessibility, widespread consumer trust, and convenience in purchasing rapid diagnostic products, enabling efficient distribution and increased uptake of HIV testing solutions across urban and semi-urban regions.
North America led the regional market with over 42% revenue share in the historical period. The leadership of North America is supported by advanced healthcare infrastructure, high awareness of early HIV screening, and strong adoption of rapid diagnostic technologies, alongside favorable reimbursement systems and robust public health initiatives promoting widespread testing and early disease detection.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott Laboratories is a global diagnostics leader with a strong presence in infectious disease testing. Its rapid diagnostic testing portfolio includes point-of-care solutions widely used for early HIV detection and large-scale screening programs across hospitals and public health systems globally.
Established in 1896 and headquartered in Basel, Switzerland, Roche is a leading diagnostics innovator with advanced immunoassay and molecular platforms. Its HIV screening solutions support early detection, monitoring, and laboratory-based confirmation of infections, strengthening global diagnostic accuracy and expanding access to reliable testing infrastructure.
Founded in 1952 and headquartered in Hercules, California, Bio-Rad Laboratories focuses on life science research and clinical diagnostics. Its immunodiagnostic systems support HIV testing workflows, quality control, and laboratory standardization, improving reliability and consistency in infectious disease detection across healthcare laboratories worldwide.
Established in 1897 and headquartered in Franklin Lakes, New Jersey, BD is a global medical technology company specializing in diagnostics and specimen collection. Its point-of-care HIV testing platforms enhance rapid screening, enabling early diagnosis and improving public health response in both developed and emerging markets.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Siemens Healthineers AG, Thermo Fisher Scientific Inc., OraSure Technologies, Inc., Chembio Diagnostics, Inc., bioLytical Laboratories Inc., and Danaher Corporation.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Sample type |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.